Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.
We send one confirmation email first. Only emails about VTVT, unsubscribe in one click. Privacy
Quoted word for word from the company's press releases filed with the SEC. Timing is the company's own guidance, not a BioRadar estimate.
Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.
| Drug | Indication | Most advanced trial | Status |
|---|---|---|---|
| Azeliragon | Alzheimer's Disease | Phase 3 · NCT02080364 | Terminated |
| Cadisegliatin | Diabetes Mellitus, Type 1 | Phase 3 · NCT06334133 | Active not recruiting |
| GK1-399 (formerly TTP399) | Type 2 Diabetes Mellitus | Phase 1/2 · NCT01474083 | Completed |
| TTP054 | Type 2 Diabetes Mellitus | Phase 2 · NCT01665352 | Completed |
| TTP273 | Type 2 Diabetes Mellitus | Phase 2 · NCT02653599 | Completed |
| TTP399 | Diabetes Mellitus, Type 1 | Phase 1/2 · NCT03335371 | Completed |
| TTP435 | Obesity | Phase 2 · NCT00779519 | Completed |
| TTP889 | Coagulation | Phase 2 · NCT00909298 | Terminated |
| TTP4000 | Alzheimer's Disease | Phase 1 · NCT01548430 | Completed |
| Aurora Kinase Inhibitor TTP607 | Advanced Cancers | Phase 1 · NCT00939172 | Withdrawn |
Also used in these trials (approved or third-party drugs, not VTVT's own candidates): Sitagliptin.
Source: ClinicalTrials.gov trials sponsored by the company, one row per candidate at its most advanced registered trial. FDA approvals: Drugs@FDA. Wrong or missing drug? Report it
VTVT holds $77.2M in cash and short-term investments (as of Sep 30, 2026) and burns about $10.8M/quarter from operations, an estimated runway of 21.4 months at that rate (BioRadar estimate, not company guidance).
Dilution pressure: 33 · Moderate
Recent financing filings on SEC EDGAR:
Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when VTVT files for a raise →
The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for VTVT and every other ticker you follow. Card required, cancel anytime.
Start 7-day free trial →